Revenue: As of FY2027 Q1, the actual value is USD 523.78 M, missing the estimate of USD 587 M.

EPS: As of FY2027 Q1, the actual value is USD -0.2, missing the estimate of USD 0.25.

EBIT: As of FY2027 Q1, the actual value is USD 3.638 M.

Consolidated Financial Highlights

Universal Corporation reported sales and other operating revenue of $523.8 million for the three months ended June 30, 2026, a decrease from $593.8 million in the prior year period, primarily due to lower tobacco sales volumes and prices. Cost of goods sold was $440.7 million in 2026, down from $479.6 million in 2025. The gross profit margin percentage decreased to 15.9% in 2026 from 19.2% in 2025. Selling, general and administrative expenses increased to $80.8 million in 2026 from $79.2 million in 2025. Restructuring and impairment costs were $0 in 2026, compared to $1.1 million in 2025. Operating income decreased to $2.3 million in 2026 from $33.8 million in 2025. Adjusted operating income (non-GAAP) was $2.3 million in 2026, down from $34.9 million in 2025. Net income (loss) attributable to Universal Corporation was - $5.0 million in 2026, a significant drop from $8.5 million in 2025. Adjusted net income (loss) attributable to Universal Corporation (non-GAAP) was - $5.0 million in 2026, compared to $9.6 million in 2025.

Segment Results

Tobacco Operations

Sales and other operating revenues for Tobacco Operations decreased by $67.6 million, or 13%, to $437.1 million in 2026 from $504.7 million in 2025. Operating income declined by $32.2 million to $3.5 million in 2026 from $35.7 million in 2025. Tobacco sales volumes were down 9%, and tobacco sales prices were down 6%. Uncommitted tobacco inventory levels were 24% as of June 30, 2026.

Ingredients Operations

Sales and other operating revenues for Ingredients Operations decreased by $2.4 million to $86.7 million in 2026 from $89.1 million in 2025. Operating income (loss) was - $0.7 million in 2026, a decrease from $1.7 million in 2025.

Balance Sheet and Liquidity

Total debt was $1,183.880 million in 2026, down from $1,239.332 million in 2025. Net debt (non-GAAP) decreased by $51.6 million to $1,013.818 million in 2026 from $1,065.454 million in 2025. Interest expense decreased by $1.3 million in the quarter ended June 30, 2026, compared to the prior year period. Universal Corporation had approximately $1.1 billion in available liquidity, comprising cash and committed and uncommitted credit lines, as of June 30, 2026.

Cash Flow from Operating Activities

Net cash used by operating activities was - $117.119 million in 2026, an improvement from - $205.103 million in 2025. Net cash used by investing activities was - $15.645 million in 2026, compared to - $11.910 million in 2025. Net cash provided by financing activities was $244.298 million in 2026, up from $134.622 million in 2025. Cash, restricted cash and cash equivalents at end of period totaled $173.593 million in 2026, compared to $178.435 million in 2025.

Outlook / Guidance

Universal Corporation expects customer demand for tobacco to align with its fiscal year sales plan, with most tobacco shipments occurring in the second half of fiscal year 2027, following historical patterns. The company is concentrating on enhancing commercial execution, facility utilization, and operational efficiencies in its ingredients business, with some improvements extending into the next fiscal year. Universal Corporation aims to bolster the ingredients platform for enduring success through leadership, systems, operational capabilities, and commercial execution enhancements.